Board Meeting held today on 14th November, 2025 to consider and approve the Unaudited Standalone & Consolidated Financial Result for the Quarter and half Year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hipolin Ltd's board approved unaudited results for Q2 and H1 FY26 (ended 30 Sept 2025). Standalone revenue from operations fell to Rs 552.36 lacs in H1 FY26 from Rs 644.66 lacs in H1 FY25, a decline of about 14%. Q2 FY26 revenue was Rs 318.08 lacs vs Rs 326.58 lacs a year ago. Despite the revenue dip, losses narrowed sharply — H1 FY26 net loss came in at Rs 38.44 lacs versus a Rs 73.12 lacs loss in H1 FY25, and Q2 FY26 standalone PAT turned marginally positive at Rs 0.46 lacs. Consolidated results are broadly similar and include subsidiary Jayantilal Bhogilal Chemicals Pvt Ltd. Operating cash flow improved from negative Rs 318.26 lacs in H1 FY25 to positive Rs 19.59 lacs in H1 FY26, and short-term borrowings were cut nearly in half to Rs 101.84 lacs. Statutory auditor SDPM & Co. issued an unmodified limited review report on both standalone and consolidated numbers.
Mixed signals for shareholders — top-line continues to shrink in the detergent business, but the company is cutting losses, improving cash generation, and reducing debt, which could support sentiment. Q2 returning to a small profit is a positive cue, though the H1 still in the red means the stock may not see a strong rally until revenue stabilises.